Orphan Products Development CAPT Jeffrey Fritsch, .R.Ph. January 23, 2009

First Page		Document Content
Pharmacology Pharmaceuticals policy Drug discovery Orphan drug Food and Drug Administration Orphan Drug Act Rare disease National Organization for Rare Disorders New Drug Application Pharmaceutical sciences Health Clinical research		Orphan Products Development CAPT Jeffrey Fritsch, .R.Ph. January 23, 2009 Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 279,60 KB Share Document on Facebook

	The NIH Undiagnosed Diseases Program J A M E S P A N • 10 J U N E 2014 Stanford University School of Medicine In the United States, a rare disease defined by the 1983 Orphan Drug Act, is a disease that aﬀects fewer DocID: 1uQtE - View Document
	Zusammenfassung der Master-Thesis von Rossella Belleli Efficiency indicators for new drugs approved by the FDA from 2003 toIn the last decades, the drug development costs have increased while the number of new dru DocID: 1pOAi - View Document
	Personalized Medicine and Companion Diagnostics: Shaping the Future of the Clinical Research Enterprise PEER REVIEWED \| Heather Harris, MSc [DOI: CR] DocID: 1p6bN - View Document
	Lhorne on DSK30JT082PROD with NOTICESFederal Register / Vol. 81, NoThursday, July 28, Notices DocID: 1oKKK - View Document
	© 2007 Nature Publishing Group http://www.nature.com/naturemedicine C O M M E N TA RY Aligning pharmaceutical innovation with medical need DocID: 1aC3u - View Document